Two Sigma Securities, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Two Sigma Securities, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.12 - $0.64 $2,290 - $12,216	19,089 New	19,089 $4,000
Q1 2022 May 16, 2022	SELL	$0.5 - $1.06 $18,289 - $38,772	-36,578 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.92 - $1.22 $32,940 - $43,682	-35,805 Reduced 49.47%	36,578 $37,000
Q3 2021 Nov 15, 2021	BUY	$0.67 - $1.51 $48,496 - $109,298	72,383 New	72,383 $94,000
Q2 2021 Aug 16, 2021	SELL	$0.75 - $1.1 $61,447 - $90,123	-81,930 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.96 - $1.74 $78,652 - $142,558	81,930 New	81,930 $86,000
Q2 2020 Aug 14, 2020	SELL	$0.52 - $0.92 $5,630 - $9,961	-10,828 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.6 - $2.31 $6,496 - $25,012	10,828 New	10,828 $6,000
Q1 2018 May 15, 2018	SELL	$0.76 - $1.32 $11,525 - $20,017	-15,165 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.1 - $1.54 $2,959 - $4,142	2,690 Added 21.56%	15,165 $18,000
Q3 2017 Nov 14, 2017	BUY	$1.19 - $1.43 $14,845 - $17,839	12,475	12,475 $16,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.